PyInvesting

Market research

SUVENPHAR.NSE Suven Pharmaceuticals Limited

NSE INR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
413B
P/E ratio
99.01
Analyst target
1396.6666
Dividend yield
Not available
Beta
1.13

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Suven Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 4.2% above its 200 day moving average.

From a valuation standpoint, the stock is 179.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.4.

Based on the above factors, Suven Pharmaceuticals Limited gets an overall score of 1/5.